Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer

Author:

Eggen Annemarie C1ORCID,Richard Nadine M2ORCID,Bosma Ingeborg3,Jalving Mathilde1ORCID,Leighl Natasha B4ORCID,Liu Geoffrey4ORCID,Mah Kenneth2ORCID,Higazy Randa5,Shultz David B5ORCID,Reyners Anna K L16ORCID,Rodin Gary2ORCID,Edelstein Kim2ORCID

Affiliation:

1. Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

2. Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

3. Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

4. Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

5. Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada

6. Center of Expertise in Palliative Care, University Medical Center Groningen, University of Groningen, the Netherlands

Abstract

Abstract Background Knowledge regarding cognitive problems in metastatic non-small cell lung cancer (mNSCLC) is limited. Such problems may include both patient-reported cognitive concerns and demonstrable cognitive impairment. Greater understanding of these outcomes is needed to inform rehabilitation strategies for these difficulties. We aimed to identify the frequency of cognitive problems and associated factors in patients with mNSCLC. Methods In this cross-sectional study, adults with mNSCLC completed validated neuropsychological tests and self-report questionnaires measuring cognitive concerns, neurobehavioral concerns, depression, demoralization, illness intrusiveness, self-esteem, and physical symptoms. Cognitive impairment (performance based) was defined according to International Cancer and Cognition Task Force criteria. Clinically significant cognitive concerns were defined by a score ≥1.5 SD below the normative mean on the Functional Assessment of Cancer Therapy-Cognitive Function Perceived Cognitive Impairment (FACT-Cog PCI). Univariate and multivariate logistic regression analyses were performed to identify associated factors. Results Of 238 patients approached, 77 participated (median age: 62 years; range: 37-82). Brain metastases were present in 41 patients (53%), and 23 (29%) received cranial irradiation. Cognitive impairment and cognitive concerns were present in 31 (40%) and 20 patients (26%), respectively. Cognitive impairment and cognitive concerns co-occurred in 10 patients (13%), but their severity was unrelated. Cognitive impairment was associated with cranial irradiation (odds ratio [OR] = 2.89; P = .04), whereas cognitive concerns were associated with greater illness intrusiveness (OR = 1.04; P = .03) and lower self-esteem (OR = 0.86; P = .03). Conclusions Cognitive impairment and cognitive concerns are both common in patients with mNSCLC but are not necessarily related, and their risk factors differ. The association of illness intrusiveness and self-esteem with cognitive concerns can inform therapeutic interventions in this population.

Funder

Princess Margaret Cancer Foundation

Ontario Ministry of Health and Long-Term Care

Publisher

Oxford University Press (OUP)

Subject

Medicine (miscellaneous)

Reference53 articles.

1. Neurocognitive deficits and neurocognitive rehabilitation in adult brain tumors;Day;Curr Treat Options Neurol.,2016

2. Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy;Cerulla Torrente;J Cancer Surviv.,2020

3. Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis;Saeed;J Cancer Surviv.,2019

4. Association of neurocognitive deficits with radiotherapy or chemoradiotherapy for patients with head and neck cancer;Zer;JAMA Otolaryngol Head Neck Surg.,2018

5. What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research;Williams;Br J Haematol.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3